A new class of peptidomimetics targeting the polo-box domain of polo-like kinase 1.
Ahn, M., Han, Y.H., Park, J.E., Kim, S., Lee, W.C., Lee, S.J., Gunasekaran, P., Cheong, C., Shin, S.Y., Kim, H.Y., Ryu, E.K., Murugan, R.N., Kim, N.H., Bang, J.K.(2015) J Med Chem 58: 294-304
- PubMed: 25347203 
- DOI: https://doi.org/10.1021/jm501147g
- Primary Citation of Related Structures:  
4RCP, 4WHH, 4WHK, 4WHL - PubMed Abstract: 
Recent progress in the development of peptide-derived Polo-like kinase (Plk1) polo-box domain (PBD) inhibitors has led to the synthesis of multiple peptide ligands with high binding affinity and selectivity. However, few systematic analyses have been conducted to identify key Plk1 residues and characterize their interactions with potent Plk1 peptide inhibitors ...